Immuno-Oncology Platform

Immuno-Oncology Platform

We're probing immune biology to deliver insights and identify your lead candidates

Overview

We've leveraged our cutting-edge technologies to build a ground-breaking platform for Immuno-oncology drug discovery. Our collection of high throughput assays allows you to rapidly identify single agents or combinations that effect T cell proliferation and polarization, tumor cell lysis, and natural killer (NK) cell function.

Gene-Editing in Immune Cells

Gene-editing in immune cells for your immuno-oncology project is now even faster than before. Leveraging the latest genome engineering tools, including CRISPR-Cas9, we're able to precisely edit T-cell, B-cell, and monocytes lines.

Request More Information

What is Immuno-Oncology?

Immuno-oncology is an area of research which investigates how a body’s own immune system can fight cancer.

Immuno-Oncology Insights In High-Throughput

immuno-oncology platform

Use our T cell proliferation and MLR assays to understand your compound’s effect on T cell activity, alone or in combination with a checkpoint inhibitor.

Our ADCC and CDC assays will measure your antibody’s efficacy in eliciting tumor cell killing responses. We have a bank of 800+ tumor cells to choose from.

Use our T cell-mediated tumor cell lysis assay to assess the activity of your Bispecific T Cell Engager (BiTE).

Back to top